Home
Conditions
Liver Cirrhosis

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

163 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area

NCT00913757

Conditions: Adenocarcinoma, Alcohol-Induced Disorders, Alcohol-Related Disorders, +26 more
Locations: University of Maryland Medical Center Baltimore, Maryland, United States

Veterans Affairs Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

NCT02078882

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations: Univeristy of California Davis Medical Center Sacramento, California, United States

View Trial Details

Completed

Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response

NCT03590886

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT

NCT03253276

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: Susanne Keiding Aarhus, Denmark

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

NCT03124108

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Schiff Center for Liver Diseases Miami, Florida, United States

Cleveland Clinic Florida Weston, Florida, United States

Piedmont Research Institute Atlanta, Georgia, United States

View all 24 locations

View Trial Details

Completed

Repeatability and Reproducibility of Quantitative MRCP

NCT03809559

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Calculi, +18 more
Locations: Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom

Oxford Centre for Clinical Magnetic Resonance Research Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

NCT02477462

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Completed

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

NCT01510860

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: Klinikum Grosshadern Munich, Germany

View Trial Details

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

NCT01904058

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations: Scripps Clinic La Jolla, California, United States

University of California at Davis Sacramento, California, United States

University of Miami Miami, Florida, United States

University of Chicago Medical Center Chicago, Illinois, United States

View all 24 locations

View Trial Details

Completed

The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital

NCT03322943

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Liver Cirrhosis

Liver Cirrhosis trial results

Related conditions